Front Row Advisors »

Regeneron Pharmaceuticals shares owned by Front Row Advisors

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Front Row Advisors from 13F filings

Historical chart of Front Row Advisors investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by Front Row Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by Front Row Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $3.5k 4 878.25
2023-09-30 $3.3k 4 823.00
2023-06-30 $3.0k 4 750.00
2023-03-31 $0 3 0.00
2022-09-30 $3.0k 4 750.00
2022-06-30 $2.0k 4 500.00
2022-03-31 $3.0k 4 750.00
2021-12-31 $3.0k 4 750.00
2021-09-30 $2.0k 4 500.00
2021-06-30 $3.0k 4 750.00
2021-03-31 $2.0k 4 500.00
2020-12-31 $17k 35 485.71
2020-09-30 $18k 35 514.29
2020-06-30 $22k 35 628.57
2020-03-31 $19k 36 527.78
2019-12-31 $14k 38 368.42
2019-09-30 $11k 38 289.47
2019-06-30 $11k 34 323.53
2019-03-31 $12k 33 363.64
2018-12-31 $12k 33 363.64
2018-09-30 $12k 33 363.64
2018-06-30 $12k 33 363.64
2018-03-31 $9.0k 27 333.33